American Vietnamese Biotech Incorporation (HNX:AMV)
1,200.00
-100.00 (-7.69%)
At close: Aug 12, 2026
HNX:AMV Market Cap
HNX:AMV has a market cap or net worth of 157.33 billion as of August 12, 2026. Its market cap has decreased by -40.00% in one year.
Market Cap
157.33B
Enterprise Value
375.59B
Revenue
102.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,200.00
ChartMarket Cap Chart
Since February 25, 2011, HNX:AMV's market cap has increased from 27.09B to 157.33B, an increase of 480.76%. That is a compound annual growth rate of 12.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 157.33B | -20.00% |
| Dec 27, 2024 | 196.66B | -61.54% |
| Dec 29, 2023 | 511.31B | 18.18% |
| Dec 30, 2022 | 432.65B | -67.02% |
| Dec 31, 2021 | 1.31T | 63.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Central Pharmaceutical Joint Stock Company No3 | 1.31T |
| Pharmedic Pharmaceutical Medicinal JSC | 1.11T |
| Vidipha Central Pharmaceutical JSC | 821.50B |
| Ben Tre Pharmaceutical JSC | 287.77B |
| Mediplantex National Pharmaceutical JSC | 228.34B |
| Vimedimex Medi-Pharma JSC | 216.94B |
| Phong Phu Pharmaceutical JSC | 161.92B |
| Tipharco Pharmaceutical JSC | 160.60B |